The Importance of the CXCL12/CXCR4 Axis in Therapeutic Approaches to Diabetes Mellitus Attenuation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Importance of the CXCL12/CXCR4 Axis in Therapeutic Approaches to Diabetes Mellitus Attenuation
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-08-10
DOI
10.3389/fimmu.2015.00403
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alginate Encapsulant Incorporating CXCL12 Supports Long-Term Allo- and Xenoislet Transplantation Without Systemic Immune Suppression
- (2015) T. Chen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Identification of transcription factors involved in the transcriptional regulation of the CXCL12 gene in rat pancreatic insulinoma Rin-5F cell line
- (2015) Jelena Marković et al. Biochemistry and Cell Biology
- Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype
- (2015) Katia Beider et al. Oncotarget
- Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
- (2014) Nathalie Esser et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- CXCL12 secreted from adipose tissue recruits macrophages and induces insulin resistance in mice
- (2014) Dayea Kim et al. DIABETOLOGIA
- Processing of CXCL12 impedes the recruitment of endothelial progenitor cells in diabetic wound healing
- (2014) Guang Feng et al. FEBS Journal
- CXC Chemokine Ligand 12 Protects Pancreatic β-Cells from Necrosis through Akt Kinase-Mediated Modulation of Poly(ADP-ribose) Polymerase-1 Activity
- (2014) Nevena Grdović et al. PLoS One
- The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
- (2014) Yvonne Döring et al. Frontiers in Physiology
- CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis
- (2013) Kosuke Tanegashima et al. FEBS LETTERS
- Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels
- (2013) Robert D. Berahovich et al. IMMUNOLOGY
- The use of stem cells for pancreatic regeneration in diabetes mellitus
- (2013) Luc Bouwens et al. Nature Reviews Endocrinology
- Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory Bowel Disease
- (2013) Lael Werner et al. Theranostics
- The Role of CXCL12-CXCR4 Signaling Pathway in Pancreatic Development
- (2013) Keiichi Katsumoto et al. Theranostics
- Impact of Diabetes on Cardiovascular Disease: An Update
- (2013) Alessandra Saldanha de Mattos Matheus et al. International Journal of Hypertension
- Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and β cell regeneration in a T1D model
- (2012) Benjamin K Nti et al. Cellular & Molecular Immunology
- The SDF-1α/CXCR4 Axis is Required for Proliferation and Maturation of Human Fetal Pancreatic Endocrine Progenitor Cells
- (2012) Ayse G. Kayali et al. PLoS One
- CXCR7 impact on CXCL12 biology and disease
- (2012) Lorena Sánchez-Martín et al. TRENDS IN MOLECULAR MEDICINE
- Dual Blockade of the Homeostatic Chemokine CXCL12 and the Proinflammatory Chemokine CCL2 Has Additive Protective Effects on Diabetic Kidney Disease
- (2011) Murthy N. Darisipudi et al. AMERICAN JOURNAL OF PATHOLOGY
- CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
- (2011) E. Righi et al. CANCER RESEARCH
- Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival
- (2011) Z. Liu et al. DIABETOLOGIA
- CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
- (2011) Fabien M. Décaillot et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CXCL12: A New Player in Coronary Disease Identified through Human Genetics
- (2011) Samira S. Farouk et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Stem cell approaches for diabetes: towards beta cell replacement
- (2011) Gordon C Weir et al. Genome Medicine
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Elevated Proinflammatory Cytokine Production by a Skewed T Cell Compartment Requires Monocytes and Promotes Inflammation in Type 2 Diabetes
- (2010) M. Jagannathan-Bogdan et al. JOURNAL OF IMMUNOLOGY
- The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and disease
- (2010) Nathan Karin JOURNAL OF LEUKOCYTE BIOLOGY
- Epigenetic phenomena linked to diabetic complications
- (2010) Luciano Pirola et al. Nature Reviews Endocrinology
- CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
- (2010) Ulrike Naumann et al. PLoS One
- SDF-1α Secreted by Human CD133-Derived Multipotent Stromal Cells Promotes Neural Progenitor Cell Survival Through CXCR7
- (2010) Benjamin Bakondi et al. STEM CELLS AND DEVELOPMENT
- Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes
- (2009) S. G. Sayyed et al. DIABETOLOGIA
- Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2)
- (2009) Z. Liu et al. DIABETOLOGIA
- The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice
- (2009) Jennifer M. Oliver-Krasinski et al. JOURNAL OF CLINICAL INVESTIGATION
- Elevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development
- (2008) Qibin Leng et al. BMC IMMUNOLOGY
- T Regulatory Cells in Autoimmune Diabetes: Past Challenges, Future Prospects
- (2008) Jeffrey A. Bluestone et al. JOURNAL OF CLINICAL IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started